Hyperosmotic mannitol induces Src kinase-dependent phosphorylation of β-catenin in cerebral endothelial cells

Journal of Neuroscience Research

Volumn 80, Issue 6, 2005, Pages 855-861

  Farkas, Attila ^a   Szatmári, Erzsébet ^a   Orbók, Anna ^a   Wilhelm, Imola ^a   Wejksza, Katarzyna ^a   Nagyoszi, Péter ^a   Hutamekalin, Pilaiwanwadee ^a   Bauer, Hannelore ^b   Bauer, Hans Christian ^b   Traweger, Andreas ^b   Krizbai, István A ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

catenin; Adherens junction; Blood brain barrier; Mannitol; Src kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALPHA CATENIN; BETA CATENIN; CADHERIN; CALCIUM CHANNEL; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; ENDOTHELIUM CELL; HYPEROSMOLARITY; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BETA CATENIN; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; DIURETICS, OSMOTIC; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; MANNITOL; OSMOTIC PRESSURE; PHOSPHORYLATION; RATS; SRC-FAMILY KINASES; TRANS-ACTIVATORS; TYROSINE; VERAPAMIL;

EID: 21844442379     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20521     Document Type: Article

References (37)

1. Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK. 2003. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem 278:11916-11924.
2. Berl T, Siriwardana G, Ao L, Butterfield LM, Heasley LE. 1997. Multiple mitogen-activated protein kinases are regulated by hyperosmolality in mouse IMCD cells. Am J Physiol 272:F305-F311.
3. Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E. 1973. Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol 152:317-325.
4. Di Ciano C, Nie Z, Szaszi K, Lewis A, Uruno T, Zhan X, Rotstein OD, Mak A, Kapus A. 2002. Osmotic stress-induced remodeling of the cortical cytoskeleton. Am J Physiol Cell Physiol 283:C850-C865.
5. Di Ciano-Oliveira C, Sirokmany G, Szaszi K, Arthur WT, Masszi A, Peterson M, Rotstein OD, Kapus A. 2003. Hyperosmotic stress activates Rho: differential involvement in Rho kinase-dependent MLC phosphorylation and NKCC activation. Am J Physiol Cell Physiol 285:C555-C566.
6. Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, McAllister LD, Bubalo JS, Kraemer DF, Fortin D, Nixon R, Muldoon LL, Neuwelt EA. 2000. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 88:637-647.
7. Dorovini-Zis K, Sato M, Goping G, Rapoport S, Brightman M. 1983. Ionic lanthanum passage across cerebral endothelium exposed to hyperosmotic arabinose. Acta Neuropathol 60:49-60.
8. Duzgun SA, Rasque H, Kito H, Azuma N, Li W, Basson MD, Gahtan V, Dudrick SJ, Sumpio BE. 2000. Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J Cell Biochem 76:567-571.
9. Gatsios P, Terstegen L, Schliess F, Haussinger D, Kerr IM, Heinrich PC, Graeve L. 1998. Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J Biol Chem 273:22962-22968.
10. Gaudry CA, Palka HL, Dusek RL, Huen AC, Khandekar MJ, Hudson LG, Green KJ. 2001. Tyrosine-phosphorylated plakoglobin is associated with desmogleins but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem 276:24871-24880.
11. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. 2003. Tight junction proteins. Prog Biophys Mol Biol 81:1-44.
12. Greenwood J, Luthert PJ, Pratt OE, Lantos PL. 1988. Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies. J Cereb Blood Flow Metab 8:9-15.
13. Greenwood J, Pryce G, Devine L, Male DK, dos-Santos WL, Calder VL, Adamson P. 1996. SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J Neuroimmunol 71:51-63.
14. Kale G, Naren AP, Sheth P, Rao RK. 2003. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 302:324-329.
15. + exchangers. J Biol Chem 274:8093-8102.
16. Ko BC, Lam AK, Kapus A, Fan L, Chung SK, Chung SS. 2002. Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J Biol Chem 277: 46085-46092.
17. 2+/Pyk2/JNK signal cascades in rat aortic smooth muscle cells. J Biochem (Tokyo) 130:351-358.
18. Kroll RA, Neuwelt EA. 1998. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42:1083-1099.
19. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. 2004. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 24:916-925.
20. Lossinsky AS, Vorbrodt AW, Wisniewski HM. 1995. Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol 24:795-806.
21. 2+ concentration in endothelium of intact rat aorta. Exp Physiol 85:151-157.
22. Nagashima T, Ikeda K, Wu S, Kondo T, Yamaguchi M, Tamaki N. 1997. The mechanism of reversible osmotic opening of the blood-brain barrier: role of intracellular calcium ion in capillary endothelial cells. Acta Neurochir Suppl 70:231-233.
23. Nemeth ZH, Deitch EA, Szabo C, Hasko G. 2002. Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol 161:987-996.
24. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B. 1991. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9:1580-1590.
25. Ozawa M, Kemler R. 1998. Altered cell adhesion activity by pervanadate due to the dissociation of β-catenin from the E-cadherin · catenin complex. J Biol Chem 273:6166-6170.
26. Owens DW, McLean GW, Wyke AW, Paraskeva C, Parkinson EK, Frame MC, Brunton VG. 2000. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell 11:51-64.
27. Pai R, Tarnawski AS, Tran T. 2004. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 15:2156-2163.
28. Pal D, Audus KL, Siahaan TJ. 1997. Modulation of cellular adhesion in bovine brain microvessel endothelial cells by a decapeptide. Brain Res 747:103-13.
29. Pardridge WM. 2002. Drug and gene delivery to the brain: the vascular route. Neuron 36:555-558.
30. Ragette R, Fu C, Bhattacharya J. 1997. Barrier effects of hyperosmolar signaling in microvascular endothelium of rat lung. J Clin Invest 100:685-692.
31. Rapoport SI. 2000. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 20:217-230.
32. Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD. 1980. Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 238:R421-R431.
33. Rizoli SB, Rotstein OD, Kapus A. 1999 Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem 274:22072-22080.
34. Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M. 1999. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 274:36734-36740.
35. Schaffler A, Arndt H, Scholmerich J, Palitzsch KD. 2000. Amelioration of hyperglycemic and hyperosmotic induced vascular dysfunction by in vivo inhibition of protein kinase C and p38 MAP kinase pathway in the rat mesenteric microcirculation. Eur J Clin Invest 30:586-593.
36. Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM. 2000. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. J Neurosurg 92:599-605.
37. Szaszi K, Buday L, Kapus A. 1997. Shrinkage-induced protein tyrosine phosphorylation in Chinese hamster ovary cells. J Biol Chem 272: 16670-16678.